New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

National Healthcare Properties, Inc.

NHP

Real Estate Reit Healthcare Facilities

National Healthcare Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $342.3 million, down 3.25% from fiscal 2024.

Revenue
+19.8%
EPS
n/m
Free cash flow
n/m
Total debt
+79.0%

Quarter to September 2026, against a year earlier

14.82 0.31 +2.14%

After hours trading: 14.82, unchanged, last trade Fri 4:01pm Eastern.

Market cap
$985.7M
P/E
n/m
Fwd P/E FY26e
16.2×
Dividend yield
1.01%
F-score
5/9
ROIC
1.83%
Net debt / EBITDA
6.4×
Payout ratio
—

Revenue to profit Twelve months to Sep 30, 2026

It lost $12.2M on $361.4M of revenue: $3.38 for every $100. What is an income statement?

Revenue to profit, in millions of dollars and as a share of revenue
Revenue361.4100.0%
Cost of revenue−229.6−63.5%
Gross profit131.736.5%
Selling, general & admin−28.4−7.9%
Other operating costs−62.9−17.4%
Operating income40.411.2%
Other income, net−52.5−14.5%
Net income−12.2−3.4%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$342M$342M$344M$361M
Operating income$3.3M$0.0B$11M$40M
Net income−$58M−$60M−$45M−$12M
Net margin (right axis)−16.9%−17.7%−13.1%−3.4%
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Revenue

+8 more TTM periods

342.28 342.12 344.32 361.36
Cost of Revenue
218.90 213.96 213.90 229.63
Gross Profit
123.38 128.16 130.42 131.72
SG&A Expenses
24.19 24.76 26.29 28.43
Operating Income
3.30 0.38 10.99 40.42
Non-operating Income/Expense
(60.82) (60.59) (55.70) (52.52)
Non-operating Interest Expenses
61.28 61.42 58.31 55.41
EBT
(57.52) (60.21) (44.71) (12.10)
Income Tax Provision
0.16 0.24 0.29 0.13
Income after Tax
(57.68) (60.45) (45.00) (12.23)
Dividends (Preferred)
13.45 13.29 12.69 11.76
Non-Controlling Interest
(0.06) (0.09) (0.09) (0.05)
Net Income Common
(71.07) (73.65) (57.60) (23.94)
EPS (Basic)
(2.51) (2.60) (1.88) (1.04)
EPS (Diluted)
(2.51) (2.60) (1.88) (1.04)
Shares (Basic, Weighted)
28.30 28.31 36.63 47.72
Shares (Diluted, Weighted)
28.30 28.31 36.63 47.72
Gross Margin
36.05% 37.46% 37.88% 36.45%
EBIT Margin
0.96% 0.11% 3.19% 11.19%
EBT margin
(16.81%) (17.60%) (12.99%) (3.35%)
Net Profit Margin
(20.76%) (21.53%) (16.73%) (6.63%)
Free Cash Flow Margin
22.83% 7.33% (18.25%) (36.55%)
EBITDA
87.86 75.21 83.16 117.64
EBIT
3.30 0.38 10.99 40.42
EPS (Diluted, from Cont. Ops)
(2.04) (2.14) (1.49) (0.77)
EPS (Diluted, Consolidated)
(2.04) (2.14) (1.49) (0.77)
EPS (Basic, Consolidated)
(2.04) (2.14) (1.49) (0.77)
EPS (Basic, from Continuous Ops)
(2.04) (2.14) (1.49) (0.77)
Income from Continuous Operations
(57.68) (60.45) (45.00) (12.23)
Consolidated Net Income/Loss
(57.68) (60.45) (45.00) (12.23)
EBITDA Margin
25.67% 21.98% 24.15% 32.56%
Operating Cash Flow Margin
2.03% 10.87% 14.74% 15.58%

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026